On April 16, 2024, Saga University Hospital and BostonGene (based in Waltham, Massachusetts, U.S.) forged a collaboration aimed at advancing biomarker research to predict the efficacy of immune checkpoint inhibitors (ICI) in patients with EGFR-positive lung cancer. Saga University Hospital,…
Novo Integrated Sciences, Inc. (NASDAQ:NVOS), a pioneer in patient-centric health and wellness, announced its financial results for the second fiscal quarter ending February 29, 2024. Robert Mattacchione, Novo’s CEO and Board Chairman, highlighted efforts during the quarter to enhance operational…
Edgewise Therapeutics, Inc. (Nasdaq: EWTX), a prominent biopharmaceutical company specializing in muscle diseases, has unveiled encouraging two-year topline results from the ARCH trial. The ARCH study, conducted at a single center, is an open-label investigation focusing on assessing safety, tolerability,…
Fresenius Kabi, a division of Fresenius, has launched Tyenne® (tocilizumab-aazg) in the U.S., a biosimilar of Actemra® (tocilizumab), approved by the FDA on March 5, 2024. Tyenne® is available in both intravenous and subcutaneous formulations, marking a significant advancement in…
QuidelOrtho Corporation (Nasdaq: QDEL) has integrated the ARK™ Fentanyl II Assay into its U.S. Vitros® XT 7600 and 5600 Integrated Systems and its Vitros® 4600 Chemistry System menu of assays as a MicroTip® Partnership Assay (“MPA”). This addition of the…
Henry Schein, Inc. (NASDAQ: HSIC), the leading provider of healthcare solutions for dental and medical practices, has added three new members to its Executive Management Committee (EMC). Steve Boggan and Bianka Wilson, who have been appointed Co-CEOs of the Global…
DaVita Inc. has announced the appointment of Dennis Pullin to its Board of Directors, effective April 10, 2024. “Pleased to welcome Dennis to DaVita’s board,” said Pamela Arway, independent chair of the DaVita Inc. Board of Directors. “Excited about the…
Baxter International Inc. (NYSE:BAX), a global leader in injectables, anesthesia, and drug compounding, has announced the expansion of its Pharmaceuticals portfolio in the U.S. with the launch of five new injectable products. Alok Sonig, Executive Vice President and Group President…
Today marks the launch of the Collective Healthcare Action to Reduce MedTech Emissions (CHARME) collaborative, aimed at cutting down greenhouse gas emissions from the extensive U.S. medical device and equipment supply chain. Representing 7% of U.S. health care greenhouse gas…
Centene Corporation (NYSE: CNC) announced today that its subsidiary, Meridian in Michigan (Meridian), has been chosen by the Michigan Department of Health and Human Services (MDHHS) to continue serving as a Medicaid health plan for the Comprehensive Health Care Program.…
UnitedHealthcare Community Plan of Pennsylvania has contributed $180,000 to the United Disabilities Services Foundation (UDSF) to bolster aging and disability services across the state. UDSF is dedicated to enhancing the lives of individuals living with disabilities, aging, or recovering from…
Paragonix Technologies, Inc., a leader in organ transplant innovations, has unveiled its annual report from the GUARDIAN-Heart Clinical Registry at the 44th ISHLT Annual Meeting and Scientific Sessions. This groundbreaking study marks the first instance where a medical device has…